LMAT

LeMaitre Vascular's stock has experienced positive movements due to strong financial performance and strategic announcements. As of April 9, 2026, the stock price was $112.71, a 38.53% increase from April 10, 2025. In February 2026, the stock surged by 24.4% following strong Q4 2025 results, including sales of $64.5 million and a 39% year-over-year increase in Q4 EPS to $0.68. The company also raised its quarterly cash dividend by 25% and authorized a $100 million share repurchase program. In May 2026, LeMaitre Vascular announced strong preliminary Q1 2026 results with net sales of $66.6 million and diluted EPS growth of 42%, raising its full-year 2026 guidance.